Pacira Pharmaceuticals, Inc.

10578 Science Center Drive
Suite 125
San Diego, CA 92121
(858) 625 2424

5 Sylvan Way
Parsippany, NJ 07054
(973) 254 3560

TAKING CARE OF PATIENTS, TODAY AND TOMORROW

Corporate Governance - Board of Directors

HighlightsManagementBoard of DirectorsCommittee Composition
David Stack, President, Chief Executive Officer and Chairman
Pacira Pharmaceuticals
David Stack, President, Chief Executive Officer and Chairman
Pacira Pharmaceuticals


Dave Stack became President, CEO, and a member of the Board of Directors of Pacira in December 2007. With more than 25 years of successful industry experience in both large public and small private companies, Mr. Stack is evolving Pacira from a sustained release injectable technology company into a fully integrated, acute care pharmaceutical company.

Mr. Stack also remains a Managing Director at MPM Capital, and President and General Partner of Stack Pharmaceuticals, Inc., a... 

Paul Hastings, Lead Director
OncoMed Pharmaceuticals
Paul Hastings, Lead Director
OncoMed Pharmaceuticals


Mr. Hastings has served as president and chief executive officer of OncoMed Pharmaceuticals since January 2006. Prior to joining OncoMed, Mr. Hastings was president and chief executive officer of QLT, Inc. Before this role, Mr. Hastings served as president and chief executive officer of Axys Pharmaceuticals, which was acquired by Celera Corporation in 2001. Prior to Axys, Mr. Hastings was president of Chiron Biopharmaceuticals and also held a variety of management positions of increasing respons... 
Laura Brege
Former CEO of Nodality, Inc.
Laura Brege
Former CEO of Nodality, Inc.


Ms. Brege served as executive vice president, corporate affairs for Onyx Pharmaceuticals until December 2011. In this role, Ms. Brege was responsible for the oversight of all external relationships including medical and scientific affairs, government affairs and public affairs.

Previously, Ms. Brege held the roles of chief operating officer and executive vice president and chief business officer for Onyx. In these roles, she oversaw the expansion of key corporate capabilities and... 

Yvonne Greenstreet, MBChB, MBA
Former Senior Vice President and Head of Medicines Development at Pfizer
Yvonne Greenstreet, MBChB, MBA
Former Senior Vice President and Head of Medicines Development at Pfizer
Mark Kronenfeld, MD
Maimonides Medical Center
Mark Kronenfeld, MD
Maimonides Medical Center
John P. Longenecker, PhD
John P. Longenecker, PhD

John P. Longenecker, Ph.D. currently serves as president, CEO and Director of HemaQuest Pharmaceuticals, a private biotechnology developing treatment for hemoglobinopathies including sickle cell disease and beta thalassemia. Dr Longenecker has 30 years’ experience in the biotech/pharmaceutical industry including the startup and growth of multiple biotechnology companies. He has led efforts in all aspects of company development from startup venture capital funding, initial and sec... 

Gary W. Pace, PhD
Gary W. Pace, PhD

Dr. Pace is a seasoned biopharmaceutical executive with over 30 years of experience in the industry. He has co-founded a number of early stage life science companies where he built products from the laboratory to commercialization.

Dr. Pace is currently founder, Director and Consultant of QRxPharma Ltd (ASX: QRX). He is also a Director of ResMed Inc (NYSE: RMD), Transition Therapeutics Inc (TSX: TTH), Celsion Corp (NASDAQ: CLN) and Peplin Limited (ASX: PEP). Dr. Pace is an elec... 

Andreas Wicki, PhD
HBM Partners AG
Andreas Wicki, PhD
HBM Partners AG


Dr. Wicki is CEO of HBM Partners AG and HBM BioVentures AG, Europe’s largest private equity focused investment company dedicated to life sciences. Prior to this, from 1990-1998, he was co-owner and CEO of ANAWA Laboratorien AG and Clinserve AG, two life sciences CRO companies which he then sold to MDS Inc., a major life sciences services and clinical research organization. After the acquisition, from 1998-2001, he was Senior Vice President of the European Analytical Operations at MDS I... 

Dennis L. Winger
Former CFO of Applera Corporation
Accuray Incorporated
Nektar Therapeutics
Dennis L. Winger
Former CFO of Applera Corporation
Accuray Incorporated
Nektar Therapeutics
Contact Investor Relations:
Susan Mesco
(973) 451-4030
Susan.Mesco@pacira.com